semaglutide sweating can cause Understanding Semaglutide: Dosage, Side Effects, Warnings and More – Barimelts Long Beach Health Department semaglutide and heat exhaustion Know

More serious side effects While very rare, some serious side effects can occur with Semaglutide

doi:10.1016/j.neuroscience.2012.09.081 131

PubMed laboratory research record [PMID: 23383563] PubMed record related to this compound for laboratory literature review

Tirzepatide (Mounjaro) a dual GLP-1/GIP agonist licensed in the UK for type 2 diabetes and, following a positive NICE technology appraisal (TA1026), recommended for weight management in eligible adults within specialist services

The tool was not used to generate scientific content, data, analyses, interpretations, or conclusions

Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges